MRKR Annual Working Capital
$14.05 M
+$5.22 M+59.01%
31 December 2023
Summary:
As of January 23, 2025, MRKR annual working capital is $14.05 million, with the most recent change of +$5.22 million (+59.01%) on December 31, 2023. During the last 3 years, it has fallen by -$3.96 million (-21.97%). MRKR annual working capital is now -76.26% below its all-time high of $59.19 million, reached on December 31, 2018.MRKR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRKR Quarterly Working Capital
$7.45 M
-$2.25 M-23.22%
30 September 2024
Summary:
As of January 23, 2025, MRKR quarterly working capital is $7.45 million, with the most recent change of -$2.25 million (-23.22%) on September 30, 2024. Over the past year, it has dropped by -$2.25 million (-23.22%). MRKR quarterly working capital is now -88.24% below its all-time high of $63.32 million, reached on March 31, 2021.MRKR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRKR Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +59.0% | -23.2% |
| 3 y3 years | -22.0% | -23.2% |
| 5 y5 years | -76.3% | -75.0% |
MRKR Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.5% | +59.0% | -77.5% | +30.5% |
| 5 y | 5-year | -67.7% | +59.0% | -88.2% | +30.5% |
| alltime | all time | -76.3% | +165.8% | -88.2% | +129.0% |
Marker Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.45 M(-23.2%) |
| June 2024 | - | $9.70 M(-17.7%) |
| Mar 2024 | - | $11.79 M(-16.1%) |
| Dec 2023 | $14.05 M(+59.0%) | $14.05 M(-15.9%) |
| Sept 2023 | - | $16.71 M(-12.2%) |
| June 2023 | - | $19.03 M(+233.4%) |
| Mar 2023 | - | $5.71 M(-35.4%) |
| Dec 2022 | $8.84 M(-73.3%) | $8.84 M(-20.6%) |
| Sept 2022 | - | $11.14 M(-29.5%) |
| June 2022 | - | $15.80 M(-30.7%) |
| Mar 2022 | - | $22.80 M(-31.1%) |
| Dec 2021 | $33.08 M(+83.7%) | $33.08 M(-23.4%) |
| Sept 2021 | - | $43.18 M(-20.6%) |
| June 2021 | - | $54.36 M(-14.1%) |
| Mar 2021 | - | $63.32 M(+251.6%) |
| Dec 2020 | $18.01 M(-58.6%) | $18.01 M(-25.9%) |
| Sept 2020 | - | $24.30 M(-18.4%) |
| June 2020 | - | $29.78 M(-23.3%) |
| Mar 2020 | - | $38.83 M(-10.7%) |
| Dec 2019 | $43.49 M(-26.5%) | $43.49 M(-8.0%) |
| Sept 2019 | - | $47.27 M(-7.0%) |
| June 2019 | - | $50.83 M(-7.7%) |
| Mar 2019 | - | $55.09 M(-6.9%) |
| Dec 2018 | $59.19 M(+1518.1%) | $59.19 M(+8472.5%) |
| Sept 2018 | - | $690.50 K(-83.3%) |
| June 2018 | - | $4.14 M(+572.8%) |
| Mar 2018 | - | $616.00 K(-83.2%) |
| Dec 2017 | $3.66 M(-40.9%) | $3.66 M(-38.4%) |
| Sept 2017 | - | $5.94 M(-30.7%) |
| June 2017 | - | $8.57 M(+106.9%) |
| Mar 2017 | - | $4.14 M(-33.0%) |
| Dec 2016 | $6.18 M(-129.0%) | $6.18 M(-17.5%) |
| Sept 2016 | - | $7.49 M(-138.8%) |
| June 2016 | - | -$19.33 M(-24.8%) |
| Mar 2016 | - | -$25.70 M(+20.3%) |
| Dec 2015 | -$21.36 M(+1986.8%) | -$21.36 M(+714.9%) |
| Sept 2015 | - | -$2.62 M(-73.3%) |
| June 2015 | - | -$9.81 M(+455.8%) |
| Mar 2015 | - | -$1.77 M(+72.5%) |
| Dec 2014 | -$1.02 M(-88.3%) | -$1.02 M(+56.0%) |
| Sept 2014 | - | -$656.20 K(-74.4%) |
| June 2014 | - | -$2.56 M(-53.5%) |
| Mar 2014 | - | -$5.51 M(-37.2%) |
| Dec 2013 | -$8.77 M(+45.1%) | -$8.77 M(+71.8%) |
| Sept 2013 | - | -$5.10 M(+7.0%) |
| June 2013 | - | -$4.77 M(-13.3%) |
| Mar 2013 | - | -$5.50 M(-9.0%) |
| Dec 2012 | -$6.04 M | -$6.04 M(+37.7%) |
| Sept 2012 | - | -$4.39 M(+14.2%) |
| June 2012 | - | -$3.84 M(+5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | -$3.63 M(+4.0%) |
| Dec 2011 | -$3.49 M(-11.8%) | -$3.49 M(+112.4%) |
| Sept 2011 | - | -$1.64 M(+24.7%) |
| June 2011 | - | -$1.32 M(-30.0%) |
| Mar 2011 | - | -$1.88 M(-52.4%) |
| Dec 2010 | -$3.96 M(+528.9%) | -$3.96 M(+242.2%) |
| Sept 2010 | - | -$1.16 M(+175.7%) |
| June 2010 | - | -$419.60 K(-61.6%) |
| Mar 2010 | - | -$1.09 M(+73.6%) |
| Dec 2009 | -$629.40 K(-79.2%) | -$629.40 K(-17.2%) |
| Sept 2009 | - | -$760.40 K(-8.8%) |
| June 2009 | - | -$833.70 K(-75.6%) |
| Mar 2009 | - | -$3.42 M(+12.8%) |
| Dec 2008 | -$3.03 M(+79.3%) | -$3.03 M(+8.2%) |
| Sept 2008 | - | -$2.80 M(+9.0%) |
| June 2008 | - | -$2.57 M(+14.1%) |
| Mar 2008 | - | -$2.25 M(+33.3%) |
| Dec 2007 | -$1.69 M(-43.6%) | -$1.69 M(+26.3%) |
| Sept 2007 | - | -$1.34 M(+55.2%) |
| June 2007 | - | -$863.20 K(-40.8%) |
| Mar 2007 | - | -$1.46 M(-51.4%) |
| Dec 2006 | -$3.00 M(+34.8%) | -$3.00 M(+8.9%) |
| Sept 2006 | - | -$2.76 M(+18.2%) |
| June 2006 | - | -$2.33 M(+11.3%) |
| Mar 2006 | - | -$2.09 M(-5.9%) |
| Dec 2005 | -$2.23 M(-11.5%) | -$2.23 M(+9.5%) |
| Sept 2005 | - | -$2.03 M(+18.2%) |
| June 2005 | - | -$1.72 M(+100.0%) |
| Mar 2005 | - | -$860.00 K(-65.8%) |
| Dec 2004 | -$2.52 M(+251.2%) | -$2.52 M(+59.9%) |
| Sept 2004 | - | -$1.57 M(+28.3%) |
| June 2004 | - | -$1.23 M(+84.2%) |
| Mar 2004 | - | -$666.30 K(-7.0%) |
| Dec 2003 | -$716.50 K(-303.0%) | -$716.50 K(-6.9%) |
| Sept 2003 | - | -$769.70 K(+2.4%) |
| June 2003 | - | -$751.90 K(+3140.9%) |
| Mar 2003 | - | -$23.20 K(-106.6%) |
| Dec 2002 | $353.00 K(-259.0%) | $353.00 K(-189.3%) |
| Sept 2002 | - | -$395.20 K(-362.8%) |
| June 2002 | - | $150.40 K(-138.8%) |
| Mar 2002 | - | -$387.30 K(+74.5%) |
| Dec 2001 | -$222.00 K(-62.8%) | -$222.00 K(+29.9%) |
| Sept 2001 | - | -$170.90 K(+49.8%) |
| June 2001 | - | -$114.10 K(-44.0%) |
| Mar 2001 | - | -$203.80 K(-65.9%) |
| Dec 2000 | -$597.30 K(+310.2%) | -$597.30 K(+218.9%) |
| Sept 2000 | - | -$187.30 K(+800.5%) |
| June 2000 | - | -$20.80 K(-73.5%) |
| Mar 2000 | - | -$78.60 K |
| Dec 1999 | -$145.60 K | - |
FAQ
- What is Marker Therapeutics annual working capital?
- What is the all time high annual working capital for Marker Therapeutics?
- What is Marker Therapeutics annual working capital year-on-year change?
- What is Marker Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Marker Therapeutics?
- What is Marker Therapeutics quarterly working capital year-on-year change?
What is Marker Therapeutics annual working capital?
The current annual working capital of MRKR is $14.05 M
What is the all time high annual working capital for Marker Therapeutics?
Marker Therapeutics all-time high annual working capital is $59.19 M
What is Marker Therapeutics annual working capital year-on-year change?
Over the past year, MRKR annual working capital has changed by +$5.22 M (+59.01%)
What is Marker Therapeutics quarterly working capital?
The current quarterly working capital of MRKR is $7.45 M
What is the all time high quarterly working capital for Marker Therapeutics?
Marker Therapeutics all-time high quarterly working capital is $63.32 M
What is Marker Therapeutics quarterly working capital year-on-year change?
Over the past year, MRKR quarterly working capital has changed by -$2.25 M (-23.22%)